Mechanisms of Drug Resistance in Ovarian Cancer and Associated Gene Targets.

Alatise, Kharimat Lora; Gardner, Samantha; Alexander-Bryant, Angela

Alatise, Kharimat Lora; Gardner, Samantha; Alexander-Bryant, Angela.

Afiliación

Alatise KL; Nanobiotechnology Lab, Department of Bioengineering, Clemson University, Clemson, SC 29634, USA.
Gardner S; Nanobiotechnology Lab, Department of Bioengineering, Clemson University, Clemson, SC 29634, USA.
Alexander-Bryant A; Nanobiotechnology Lab, Department of Bioengineering, Clemson University, Clemson, SC 29634, USA.

Cancers (Basel) ; 14(24)2022 Dec 18.

Article en En | MEDLINE | ID: mdl-36551731

Palabras clave

RNAi therapeutics; chemoresistance; drug resistance; gene targets; ovarian cancer

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Cancers (Basel) Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google